missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Human VEGF (Research Grade Bevacizumab Biosimilar) Antibody, R&D Systems™
Human Monoclonal Antibody
Brand: R&D Systems MAB9947-SP
Denna artikel kan inte returneras.
Se returpolicy
Beskrivning
VEGF Monoclonal specifically detects VEGF in Human samples. It is validated for Neutralization.
Specifikationer
| VEGF | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| Human | |
| Protein A or G purified from cell culture supernatant | |
| Primary | |
| Detects human VEGF based on Bevacizumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Bevacizumab. This product is for research use only. | |
| Human | |
| Lyophilized |
| Neutralization | |
| Hu101 | |
| Neutralization 10-80 ng/mL | |
| MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor | |
| Human VEGF-A | |
| 25 μg | |
| 7422.0 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C, as supplied. 1 month, 2 to 8 °C under sterile conditions after opening. 6 months, -20 to -70 °C under sterile conditions after opening. | |
| IgG1 |
Korrigering av produktinnehåll
Din input är viktig för oss. Fyll i det här formuläret för att ge feedback relaterad till innehållet på denna produkt.
Produkttitel
Hittar du en möjlighet till förbättring?Dela en innehållskorrigering